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Abstract
 
Immature CD4
 
1
 
CD8
 
1
 
 thymocytes rearrange their T cell receptor (TCR)-
 
a
 
 gene locus to
generate clonotypic 
 
a
 
/
 
b
 
 TCR, after which a few cells expressing selectable TCR are signaled
to further differentiate into mature T cells. Because of requirements for self-tolerance, imma-
ture CD4
 
1
 
CD8
 
1
 
 thymocytes are programmed to die in the thymus in response to a variety of
stimuli that do not induce death of mature T cells. We now demonstrate that, in contrast to all
previously described stimuli, immature CD4
 
1
 
CD8
 
1
 
 thymocytes are selectively more resistant
than mature T cells to apoptotic death induced by DNA intercalating agents. Importantly, we
demonstrate that DNA intercalating agents induce double-stranded DNA breaks in both im-
mature thymocytes and mature T cells, but immature thymocytes tolerate these DNA breaks,
 
whereas mature T cells are signaled to die by an 
 
Atm
 
-dependent but 
 
p53
 
-independent death
mechanism. Thus, our results indicate that absence of an 
 
Atm
 
-dependent but 
 
p53
 
-independent
pathway allows immature thymocytes to survive double-stranded DNA breaks. It is likely that
the unique ability of immature thymocytes to survive DNA-damaging intercalating agents re-
flects their tolerance of double-stranded DNA breaks that occur normally during antigen re-
ceptor gene rearrangements.
Key words: DNA damage • apoptosis • thymic development • actinomycin D • 
rearrangement
 
Introduction
 
Within the thymus, immature thymocytes undergo an or-
dered process of TCR gene rearrangements to build the an-
tigen-specific TCR complex (1). Surface expression of the
 
a
 
/
 
b
 
 TCR first occurs at the CD4
 
1
 
CD8
 
1
 
 (double-positive
[DP]) stage (2), and it is at this stage that cells are screened for
the specificity of the TCR they express (3). Only 3–5% of
immature DP thymocytes are selected to mature into long-
lived T cells (4), with the remainder dying either of neglect
or in response to active negative selection (3). It is thought
that immature thymocytes are programmed to die of neglect
unless actively rescued by TCR-mediated positive selection
(5). Indeed, immature DP thymocytes are induced to die by
many different stimuli, including those that induce mature T
cells to grow and proliferate (6). The paradoxical death re-
sponse of immature thymocytes to stimuli that activate ma-
ture T cells is thought to reflect requirements for self-toler-
ance during selection of the T cell repertoire in developing
thymocytes (7). Death of immature thymocytes during de-
velopment is mediated by apoptosis and can be blocked by
inhibitors of protein synthesis such as cycloheximide (CHX)
and inhibitors of transcription such as actinomycin D (ActD;
reference 6).
Consequently, we were surprised to discover in this study
that ActD and other DNA intercalating agents induced death
of mature T cells but not immature thymocytes, despite in-
ducing DNA breaks in both cell types. We show that death
of mature T cells induced by DNA intercalating agents is
 
due to an apoptotic mechanism mediated by an 
 
Atm
 
-depen-
dent but 
 
p53
 
-independent response to DNA damage that is
not activated in immature thymocytes. Thus, DNA-damag-
ing intercalating agents are the first identified death stimuli to
which immature thymocytes are resistant relative to their
mature progeny. It is likely that the resistance of immature
thymocytes to DNA-damaging intercalating agents reflects a
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necessary tolerance to DNA breaks that occur normally dur-
ing TCR gene rearrangements.
 
Materials and Methods
 
Mice.
 
Normal C57BL/6 (B6) mice were obtained from
the Frederick Cancer Research and Development Center.
B6Smn.C3H-
 
gld
 
 (B6.
 
gld
 
) mice deficient in Fas ligand were ob-
tained from The Jackson Laboratory. The creation of 
 
Atm
 
-defi-
cient mice (allele designation Atm
 
ins5790neo
 
) has been previously
described (8). Progeny of heterozygous matings were genotyped
by PCR (9). 
 
p53
 
2
 
/
 
2
 
 mice were obtained from Taconic Laborato-
ries, and 
 
p53
 
 genotyping was performed by PCR as described
(10). Bcl-2–transgenic mice expressing human Bcl-2 under the
control of the proximal lck promoter in T lineage cells have been
described (11). All mice were housed in a specific pathogen–free
facility and used at 4–12 wk of age.
 
Cell Isolations and Culture.
 
Single-cell suspensions of thymo-
cytes or splenocytes from mice were cultured overnight (12–
16 h) at a density of 2 
 
3 
 
10
 
6
 
 cells/ml in cell culture medium con-
taining 10% FCS (Hyclone), after which they were counted in a
hemocytometer. CD4
 
1
 
CD8
 
1
 
 (DP) thymocytes were isolated by
panning on anti-CD8 coated plates as described (12) and were
routinely 96–99% pure. ActD obtained from Sigma-Aldrich was
used at concentrations ranging from 3 to 30 
 
m
 
g/ml. CHX
(Sigma-Aldrich) was used at 10 
 
m
 
g/ml. ZVAD-FMK and ZFA-
FMK were obtained from Enzyme Systems. The intercalating
agent dihydroethidium (DhE) was obtained from Molecular Probes.
The transcription inhibitor 5, 6-dichloro-1-
 
b
 
-
 
D
 
-ribofuranosyl-
benzimidazole (DRB) was obtained from Sigma-Aldrich. To cal-
culate recovery of a cell population, we multiplied the frequency
of that given cell population determined by flow cytometry with
the overall cell recovery. Data were normalized to the number of
cells recovered when cells were cultured in medium alone, in
which case recoveries were from 75 to 90%.
 
Flow Cytometric Analysis.
 
Single-cell suspensions of thymo-
cytes or splenocytes were assessed by three-color flow cytometry
using anti-CD8 CY5 (CT-CD8a; Caltag); anti-CD4–PE (GK1.5;
Becton Dickinson), and anti–Qa-2–biotin (clone 1-1-2; Phar-
Mingen), followed by streptavidin conjugated to fluorescein
(Caltag). In some experiments, cells were stained with either
anti–Qa-2–biotin for thymocytes or anti–TCR-
 
b
 
–biotin (clone
H57-597; PharMingen) for splenocytes, followed by streptavidin
conjugated to CY5 (Caltag). Cells were then stained with an-
nexin V–FITC and propidium iodide (PI; PharMingen).
 
Immunofluorescence.
 
Approximately 3 
 
3
 
 10
 
6
 
 lymphocytes were
collected, washed twice with PBS, suspended in 250 
 
m
 
l, and trans-
ferred onto a 24-well plate containing coverslips coated with 150
 
m
 
g/ml poly-
 
l
 
-lysine. Cells were spun at 1,100 rpm for 10 min to at-
tach cells onto the coverslip, fixed with methanol at 
 
2
 
20
 
8
 
C for 20
min, washed three times with PBS, blocked with 2.5% goat se-
rum 
 
1
 
 1% BSA at room temperature for 60 min at 4
 
8
 
C, incubated
with 
 
g
 
-H2AX primary antibody (13, 14) for 1 h, washed, and incu-
bated with Alexa 488–conjugated goat anti–rabbit secondary anti-
body. Nuclear counterstaining was performed by incubating slides
with 1:500 Topro-3 (Molecular Probes) for 25 min. Slides were then
mounted with Mowiol and examined using confocal microscopy.
 
Results
 
Selective Resistance of Immature Thymocyte Subpopulations to
Death Mediated by ActD.
 
To examine the effect of ActD
 
on thymocytes, single-cell suspensions of thymocytes were
cultured overnight in 10 
 
m
 
g/ml of ActD, following which
cells were harvested, counted, and analyzed by flow cy-
tometry for surface expression of CD4, CD8, and the mat-
uration marker Qa-2. Overall cell recoveries were mini-
mally affected by treatment with ActD (Fig. 1). Flow
cytometric analysis, however, revealed selective loss of spe-
cific thymocyte populations. Surface expression of Qa-2
defines populations of thymocytes that are mature and have
achieved functional competence (15, 16). Immature CD4
 
1
 
CD8
 
1
 
 (DP) thymocytes are uniformly Qa-2
 
2
 
, whereas
mature single-positive (SP) T cells in extrathymic periph-
eral tissues are uniformly Qa-2
 
1
 
. Expression of Qa-2 by SP
thymocytes is acquired relatively late during intrathymic
maturation, such that only 30–40% of CD4 SP thymocytes
are Qa-2
 
1
 
, whereas 85–90% of CD8 SP thymocytes are
Qa-2
 
1
 
. Surprisingly, we found that sensitivity to ActD
treatment correlated with expression of Qa-2 in that all
Qa-2
 
1
 
 thymocyte populations were depleted by treatment
with ActD (Fig. 1 A and cell recoveries in Fig. 1 B). In
contrast, immature Qa-2
 
2
 
 thymocytes, which includes DP
and immature CD4 SP thymocytes, were selectively resis-
tant to ActD treatment.
As mature SP thymocytes were sensitive to ActD, we
asked whether splenic T cells that are uniformly mature
and Qa-2
 
1
 
 (15) would be similarly sensitive to ActD treat-
ment. We treated single-cell suspensions of splenocytes
with ActD in overnight cultures (Fig. 1 B). As was the case
with mature Qa-2
 
1
 
 thymocytes, CD4 SP and CD8 SP Qa-2
 
1
 
splenic T cells were uniformly sensitive to ActD. Thus, im-
mature Qa-2
 
2
 
 thymocytes are resistant to death induced by
ActD whereas mature Qa-2
 
1
 
 T cells are sensitive to ActD-
induced death.
Because the cellular pattern of death induced by ActD
(mature T cells 
 
.. 
 
immature thymocytes) was opposite to
that observed in normal lymphocytes with all other stimuli
(6), we wished to characterize the death induced by ActD
further. Death in a variety of systems results from cleavage
of preformed protease procaspases to active caspases (17).
As is evident in Fig. 2 A, addition of the caspase inhibitor
ZVAD-FMK to cultures prevented death induced by
ActD, whereas addition of the control peptide ZFA-FMK
had no effect. Thus, the death induced by Act-D is caspase
dependent. This death was prevented by overexpression of
the antiapoptotic protein Bcl-2, as CD8 SP thymocytes
from Bcl-2–transgenic mice were completely protected
from the effects of ActD in overnight culture (Fig. 2 B,
top). ActD-induced death was not dependent on Fas–Fas
ligand interactions, as CD8 SP thymocytes from B6.
 
gld
 
mice were also sensitive to ActD (Fig. 2 B, bottom). The
death of mature Qa-2
 
1
 
 T cells induced by ActD is the re-
sult of apoptosis, as further revealed by annexin V
 
1
 
 staining
of viable cells while they are still PI
 
2
 
 (Fig. 2 C). Thus, the
death induced by ActD in mature T cell subpopulations
operates by a Bcl-2–regulated apoptotic pathway that re-
sults in caspase activation and that is independent of Fas–Fas
ligand interactions.
ActD is a transcriptional inhibitor that functions by in- 
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tercalating into DNA (18) and as such eventually inhibits
protein synthesis. To elucidate the mechanism of ActD-
induced death, we first treated thymocytes with the protein
synthesis inhibitor CHX to ask whether ActD-induced
death was due to its inhibition of protein synthesis. In fact
this was not the case, as inhibition of protein synthesis with
CHX neither induced Qa-2
 
1
 
 thymocyte death nor pro-
tected these cells from death induced by ActD (Fig. 3 A).
We next examined whether transcriptional inhibition was
the basis for ActD-induced death of Qa-2
 
1
 
 thymocytes by
assessing the effect of DRB, a transcriptional inhibitor that
does not intercalate into DNA but instead directly inhibits
RNA polymerase II (19). DRB was unable to induce death
of Qa-2
 
1
 
 thymocyte subpopulations (Fig. 3 B), even
though the concentration of DRB used was sufficient to
prevent CD4 and CD8 transcription (not shown). Finally,
we considered that ActD-induced death of mature Qa-2
 
1
 
T cells resulted from its intercalation into DNA by assessing
 
the effect of a different intercalating agent, DhE (a deriva-
tive of ethidium bromide that is able to enter living cells).
Importantly, DhE did induce death of thymocyte subpopu-
lations in a pattern identical to that induced by ActD (Fig.
3 C). Mature Qa-2
 
1
 
 cells were selectively lost in cell cul-
tures treated with DhE, whereas Qa-2
 
2
 
 cells again re-
mained resistant. Thus, mature T cells but not immature
thymocytes are susceptible to death induced by DNA in-
tercalating agents.
 
A Pathway of DNA Damage Response in Mature but Not Im-
mature T Cells.
 
The ability of DNA intercalating agents to
induce cells to die suggested that such death might be a cel-
lular response to DNA damage. We therefore wished to ex-
amine whether DNA intercalating agents such as ActD in-
flicted DNA damage in treated T cells. However, the
process of apoptosis itself results in oligonucleosomal frag-
mentation of DNA (6) after caspase activation. We there-
fore examined LNT cells from Bcl-2–transgenic mice, as
Figure 1. Differential resis-
tance of immature thymocytes
and mature T cells to ActD-
induced death. (A) Qa-21 ma-
ture thymocytes are selectively
susceptible to ActD-induced
death. 2 3 106 thymocytes were
cultured overnight, either in me-
dium alone or in medium con-
taining 10 mg/ml of ActD.
Contour plots depicting surface
expression of CD4 versus CD8,
and Qa-2 expression on gated
CD4 SP, CD8 SP, or DP thymic
subpopulations is shown. Death
of Qa-21 cells occurs 8–16 h af-
ter initiation of culture. (B) Cell
recoveries of ActD-treated T cell
subpopulations. To compare dif-
ferent populations on the same
graph, the data are normalized
such that recoveries in medium
alone (open bars) are represented
at 100%, with the absolute num-
ber of cells in each subpopula-
tion recovered indicated within
the bar. Recoveries in ActD
(filled bars) are represented as a
percentage of cells recovered
when cultured in medium alone.
Error bars represent 1 SEM. DP
Qa-21 thymocytes and splenic T
cells as well as Qa-22 CD8 SP
thymocytes do not constitute
defined populations and so are
labeled “Not defined.” Recov-
eries of total, DP, CD4 SP, or
CD8 SP populations are shown
among Qa-22 thymocytes, Qa-21
thymocytes, and splenic T cells
(all Qa-21). 
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Bcl-2–transgenic cells do not fragment DNA in response to
apoptotic signals that otherwise induce death in nontrans-
genic T cells (17). To examine whether DNA intercalating
agents were indeed inducing DNA damage, we examined
phosphorylation of histone H2AX on serine residue 139
(Fig. 4). Serine phosphorylation of histone H2AX on posi-
tion 139 is known to result from a wide variety of DNA-
 
damaging insults that produce DNA double-stranded breaks
(dsbs) and is an early and specific indicator of DNA damage
(13, 14). We therefore compared the level of serine phos-
phorylation of H2AX (
 
g
 
-H2AX) in ActD-treated LN ma-
ture T cells (95% T cells) by immunostaining. Untreated
LNT cells showed essentially no 
 
g
 
-H2AX in overnight
culture (Fig. 4). Upon addition of ActD, multiple foci of
Figure 2. Death of Qa-21 T cells induced by ActD is apoptosis mediated by caspases. (A)
ActD-induced death requires activation of caspases. Single-cell suspensions of B6 thymocytes
were cultured overnight in medium (open bars), ActD alone, with the caspase inhibitor ZVAD in
the presence of ActD, or with control ZFA in the presence of ActD (all filled bars). Cell recover-
ies of Qa-21 CD8 SP thymocytes are shown normalized to recovery in medium alone. (B) Death
of cells treated with ActD is prevented by Bcl-2 and does not require Fas–Fas ligand interaction.
Single-cell suspensions of thymocytes from B6 control mice, mice expressing a Bcl-2 transgene in
T lineage cells, or B6.gld mice were cultured overnight in medium alone (open bar) or ActD
(filled bars). Recoveries of representative CD8 SP cells (Qa-21) are shown normalized to recoveries of cells cultured in medium alone. (C) Death of cells
treated with ActD results from apoptosis. Single-cell suspensions of thymocytes or splenocytes were cultured overnight in medium alone (dashed line) or
ActD (solid line) and then stained with annexin V, PI, and either Qa-2 or TCR-b. Annexin V staining on PI2 cells is shown for Qa-22 thymocytes, Qa-21
thymocytes, and TCR-b1 splenic T cells and reveals the translocation of phosphatidylserine from the inner to the outer leaflet of the membrane before
the loss of membrane integrity. Percentages of annexin V1 cells in cultures with ActD are indicated, after subtraction of the percentage of annexin V1
cells in cultures with medium alone. expt., experiment.
Figure 3. Mechanism of ActD-induced death. (A) Inhibition of protein synthesis is not sufficient to induce cell death. Single-cell suspensions of thy-
mocytes from B6 mice were cultured overnight in medium alone (open bar), ActD, or CHX at 10 mg/ml. Some cells were pretreated with CHX for 6 h be-
fore addition of ActD (CHX 1 ActD). Cell recoveries of CD8 SP Qa-21 cells are shown and are normalized to the recovery in medium alone. The con-
centration of CHX used was sufficient to prevent CD4 and CD8 protein synthesis (not shown). (B) Transcriptional inhibition is not sufficient to induce
cell death. Single-cell suspensions of thymocytes from B6 mice were cultured overnight in medium alone (open bar), ActD, or graded doses of the tran-
scriptional inhibitor DRB (all filled bars). Cell recoveries of CD8 SP Qa-21 cells are shown and are normalized to the recovery in medium alone. (C)
The DNA intercalating agent DhE also induces death of Qa-21 thymocytes. Single-cell suspensions of B6 thymocytes were cultured in medium alone
(open bars), ActD, or in graded doses of the intercalating agent DhE that is able to enter live cells (all filled bars). Cell recoveries of Qa-21 cells are shown
normalized to the recovery of cells cultured in medium alone. Recoveries of Qa-22 thymocytes is shown in the left panel and those of Qa-21 thymocytes
in the right panel. 
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g
 
-H2AX were visible in LNT cells. Thus, DNA intercalating
agents such as ActD induce DNA damage in mature T cells.
To determine if ActD also induced DNA damage in im-
mature thymocytes, we next examined 
 
g
 
-H2AX in un-
treated and ActD-treated immature thymocyte populations
(Fig. 4). Interestingly, we found that immature thymocytes,
unlike mature LNT cells, had a few 
 
g
 
-H2AX foci even in
the absence of ActD, indicative of dsbs occurring during
TCR gene rearrangements, a point that will be addressed in
further experiments elsewhere. Importantly, the number of
 
g-H2AX foci increased dramatically in immature thy-
mocytes after ActD treatment, indicating that ActD induced
DNA damage in both immature thymocytes and mature T
cells. We conclude that immature thymocytes and mature T
cells do not differ in the DNA damage inflicted by ActD
but do differ in their response to this type of DNA damage.
To gain further insight into the mechanism of death in-
duced by DNA intercalating agents, we assayed mutant
strains of mice engineered to lack molecules important for
the cellular response to DNA damage. We compared mice
deficient in either p53 (10) or Atm (8) with wild-type mice
(Fig. 5). Cells from p532/2 mice were indistinguishable
from wild-type cells in that Qa-22 thymocytes were resis-
tant to death induced by ActD, whereas Qa-21 T cells in
both thymus and spleen were sensitive to death induced by
ActD in a dose-dependent manner. In contrast, Atm2/2
cells were relatively resistant to death induced by ActD. In-
deed, Qa-21 cells from Atm2/2 mice were resistant to
doses of ActD that resulted in the death of the majority of
Qa-21 cells from wild-type and p532/2 mice. These data
confirm that the mechanism of death induced by ActD is
due to a cellular response to DNA damage and demonstrate
that death of Qa-21 mature T cells is due to an Atm-depen-
dent but p53-independent pathway.
Discussion
We have demonstrated a novel pathway of death that re-
sults from DNA damage induced by DNA intercalating
agents in quiescent mature T cells. This death induces
Figure 4. ActD induces dsbs as indicated by phos-
phorylation of the oligonucleosomal histone H2AX
on serine 139 (g-H2AX). LNT cells from mice trans-
genic for Bcl-2 were cultured either in medium alone
or in ActD at 10 mg/ml. Thymocytes from Bcl-2–
transgenic mice or B6 mice were also cultured in me-
dium or ActD at 10 mg/ml. The level of g-H2AX
within cultured cells was then visualized by immu-
nostaining (green fluorescence). Nuclear counterstain-
ing was performed with Topro-3 (red fluorescence).896 Resistance of Immature Thymocytes to Apoptosis Induced by DNA Damage
phosphatidylserine translocation from the inner to the outer
leaflet of the plasma membrane before loss of membrane in-
tegrity, results from caspase activation, and can be regulated
by Bcl-2, and so we conclude that death is due to cellular
apoptosis. In mature T cells, apoptosis results from an Atm-
dependent signaling pathway that does not require the tumor
suppressor gene p53. In contrast to mature T cells, imma-
ture thymocytes are uniquely resistant to apoptosis induced
by this Atm-dependent signaling pathway even though
their DNA is also damaged, likely reflecting the necessity
for immature thymocytes to tolerate dsbs that occur nor-
mally during rearrangement of clonotypic TCRs (20).
Immature thymocytes and mature T cells have been pre-
viously shown to respond very differently to the same stim-
uli (for review see references 5 and 6). Indeed, immature
DP thymocytes die in response to a wide variety of stimuli
that do not result in death of mature T cell populations (6).
We were therefore surprised to discover that immature
thymocytes were resistant to death that was induced in ma-
ture T cells by DNA intercalating agents, as we knew of no
other stimulus resulting in this pattern of cell death in nor-
mal lymphocytes. Immature DP thymocytes represent a
unique stage of T cell differentiation at which cells rear-
range and express their TCR-a locus to generate the clo-
notypic a/b TCR (2). It is known that rearrangement at
the TCR-a locus results in recombination activating gene–
mediated DNA breaks (20), and sequential rearrangements
at the TCR-a locus may impose a particularly heavy bur-
den of DNA breaks on this cell population (21). It is likely
that developmentally regulated alterations in the cellular
response to DNA dsbs are required to prevent apoptosis of
immature thymocytes undergoing receptor rearrangements
and that these specific alterations are responsible for the
unique ability of immature thymocytes to tolerate DNA
breaks induced by DNA intercalating agents.
Whereas immature DP thymocytes do not die in re-
sponse to ActD-induced DNA damage, DP thymocytes do
die in response to DNA damage induced by gamma irradi-
ation. The altered cellular pattern of cell death to DNA
damage induced by ActD versus gamma irradiation reflect
differing molecular responses to the DNA damage inflicted
by these two different stimuli. Death of quiescent lympho-
cytes from DNA damage induced by gamma irradiation re-
quires p53, with the role of ATM still unresolved (22, 23).
In contrast, our study demonstrates that death from DNA
damage induced by ActD is Atm dependent but p53 inde-
pendent. These differing molecular responses to DNA
damage induced by ActD versus gamma irradiation likely
reflect differences in the type of DNA damage that these
two different stimuli inflict. Gamma irradiation damages
DNA by producing free radicals, whereas DNA intercalat-
ing agents alter DNA sites that may then be cleaved by en-
zymes such as topoisomerases, resulting in dsbs (24). Im-
portantly, this study demonstrates that the Atm-dependent
but p53-independent apoptotic death pathway that is acti-
vated by DNA intercalating agents in quiescent mature T
cells is not activated in immature thymocytes. Even though
the Atm gene itself is expressed in immature thymocytes
(25), we suspect that upstream activators or downstream
substrates of Atm are more likely to be modulated in im-
mature thymocytes to inhibit apoptosis than the Atm gene
itself. Unfortunately, little is yet known about the mecha-
nism by which Atm is activated in response to DNA dam-
age (26), but it is clear that Atm regulates the activity of a
growing list of substrates other than p53, including c-abl,
Brca-1 and 2, and nuclear factor kB (27–29). In this regard,
a  p53-independent pathway of apoptosis in response to
DNA damage that requires IFN regulatory factor 1 has
been previously demonstrated in lymphoblasts, although
not in quiescent T cells (30, 31).
In conclusion, our results indicate that downregulation
of an Atm-dependent, p53-independent death pathway al-
lows immature thymocytes undergoing antigen receptor
gene rearrangements to tolerate dsbs.
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